APBI 2016

EndoPredict (Myriad genetics USA)

HR+ / HER2- , T1-2, N0 FFPE samples 11 GENES PROLIFERATION, ESTROGEN (8 genes) + 3 REF LOCAL TEST (providing dedicated equipment and learning phase)

STC2 AZGP1 IL65T RBBP8 MGP

UBE2C BIRC5 DHCR7

RECURRENCE (at 5 and 10 years)

LOW RISK: + HT / NO CHEMOTHERAPY HIGH RISK: + HT / + CHEMOTHERAPY